We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microbot Designed to Be Driven Through Blood Vessels

By LabMedica International staff writers
Posted on 25 Jan 2012
Korean scientists are developing microscopic-scale medical robots that represent a new type of therapeutic technology. More...
As anticipated, the microbots, which are less than 1 mm in size, may someday be able to travel throughout the human bloodstream to deliver drugs to specific targets or hunt and destroy tumors, blood clots, and infections that cannot be easily accessed in other ways.

One hurdle in the utilization of microbots, however, is developing a system to effectively “drive’ them and steer them through the complicated and intricate circulatory system, to a defined destination. Researchers from Hanyang University (Seoul, Korea) and Chonnam National University (Gwangju, Korea) described at the American Institute of Physics’ (AIP) Proceedings of the 56th annual conference on Magnetism and Magnetic Materials, held in Scottsdale (AZ, USA), in November 2011, a new navigation system that employed an external magnetic field to generate two distinctive types of microbot movements: helical, which push the microbots forward or backward, or even allow them to “dig” into blood clots or other obstructions; and translational, which allow the ‘bots to, for example, swerve into one side of a branched artery. In laboratory experiments, the researchers used the system to steer accurately a microbot through a mock blood vessel filled with water.

The research, according to the scientists, could be extended to the “precise and effective manipulation of a microbot in several organs of the human body, such as the central nervous system, the urinary system, the eye, and others.”

The study’s findings were part of the Proceedings of the 56th annual conference on Magnetism and Magnetic Materials, planned for publication in the Journal of Applied Physics in April 2012. The research was also published December 16, 2011, in a journal of the American Institute of Physics.

Related Links:
Hanyang University
Chonnam National University


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.